0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Premature Ejaculation Treatment Market Insights, Forecast to 2029
Published Date: September 2023
|
Report Code: QYRE-Auto-17N9301
Home | Market Reports | Health| Reproductive Health
Global Premature Ejaculation Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Premature Ejaculation Treatment Market Insights, Forecast to 2029

Code: QYRE-Auto-17N9301
Report
September 2023
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Premature Ejaculation Treatment Market Size

The global Premature Ejaculation Treatment market is projected to grow from US$ 3149.9 million in 2023 to US$ 5341.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period.

Premature Ejaculation Treatment Market

Premature Ejaculation Treatment Market

Common treatment options for premature ejaculation include behavioral techniques, topical anesthetics, medications and counseling. Keep in mind that it might take time to find the treatment or combination of treatments that will work for you. Behavioral treatment plus drug therapy might be the most effective course.
Market Analysis and Insights: Global Premature Ejaculation Treatment Market
Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.
Report Includes
This report presents an overview of global market for Premature Ejaculation Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Premature Ejaculation Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Premature Ejaculation Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Premature Ejaculation Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Premature Ejaculation Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by distribution channel, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Premature Ejaculation Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Novartis, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, Bayer, Menarini, Teva and Sunrise Pharma, etc.

Scope of Premature Ejaculation Treatment Market Report

Report Metric Details
Report Name Premature Ejaculation Treatment Market
Accounted market size in 2023 US$ 3149.9 million
Forecasted market size in 2029 US$ 5341.1 million
CAGR 9.2
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Antidepressants(SSRIs)
  • Phosphodiesterase-5 Inhibitors
  • Topical Anesthetics
  • Analgesics
  • Other Treatment
Segment by Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Novartis, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, Bayer, Menarini, Teva, Sunrise Pharma, Regent Pacific, Torrent Pharma, Vivus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Premature Ejaculation Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Premature Ejaculation Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by distribution channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by distribution channel and by country, revenue for each segment.
  • Chapter 7: Europe by type, by distribution channel and by country, revenue for each segment.
  • Chapter 8: China by type and by distribution channel revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by distribution channel and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by distribution channel and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Premature Ejaculation Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Premature Ejaculation Treatment Market growing?

Ans: The Premature Ejaculation Treatment Market witnessing a CAGR of 9.2 during the forecast period 2023-2029.

What is the Premature Ejaculation Treatment Market size in 2029?

Ans: The Premature Ejaculation Treatment Market size in 2029 will be US$ 5341.1 million.

Who are the main players in the Premature Ejaculation Treatment Market report?

Ans: The main players in the Premature Ejaculation Treatment Market are Pfizer, Novartis, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, Bayer, Menarini, Teva, Sunrise Pharma, Regent Pacific, Torrent Pharma, Vivus

What are the Type segmentation covered in the Premature Ejaculation Treatment Market report?

Ans: The Types covered in the Premature Ejaculation Treatment Market report are Antidepressants(SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antidepressants(SSRIs)
1.2.3 Phosphodiesterase-5 Inhibitors
1.2.4 Topical Anesthetics
1.2.5 Analgesics
1.2.6 Other Treatment
1.3 Market by Distribution Channel
1.3.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Distribution Channel, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Premature Ejaculation Treatment Market Perspective (2018-2029)
2.2 Global Premature Ejaculation Treatment Growth Trends by Region
2.2.1 Premature Ejaculation Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Premature Ejaculation Treatment Historic Market Size by Region (2018-2023)
2.2.3 Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029)
2.3 Premature Ejaculation Treatment Market Dynamics
2.3.1 Premature Ejaculation Treatment Industry Trends
2.3.2 Premature Ejaculation Treatment Market Drivers
2.3.3 Premature Ejaculation Treatment Market Challenges
2.3.4 Premature Ejaculation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Premature Ejaculation Treatment by Players
3.1.1 Global Premature Ejaculation Treatment Revenue by Players (2018-2023)
3.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Premature Ejaculation Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Premature Ejaculation Treatment Market Concentration Ratio
3.4.1 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premature Ejaculation Treatment Revenue in 2022
3.5 Global Key Players of Premature Ejaculation Treatment Head office and Area Served
3.6 Global Key Players of Premature Ejaculation Treatment, Product and Application
3.7 Global Key Players of Premature Ejaculation Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Premature Ejaculation Treatment Breakdown Data by Type
4.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2018-2023)
4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2024-2029)
5 Premature Ejaculation Treatment Breakdown Data by Distribution Channel
5.1 Global Premature Ejaculation Treatment Historic Market Size by Distribution Channel (2018-2023)
5.2 Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2024-2029)
6 North America
6.1 North America Premature Ejaculation Treatment Market Size (2018-2029)
6.2 North America Premature Ejaculation Treatment Market Size by Type
6.2.1 North America Premature Ejaculation Treatment Market Size by Type (2018-2023)
6.2.2 North America Premature Ejaculation Treatment Market Size by Type (2024-2029)
6.2.3 North America Premature Ejaculation Treatment Market Share by Type (2018-2029)
6.3 North America Premature Ejaculation Treatment Market Size by Distribution Channel
6.3.1 North America Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023)
6.3.2 North America Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029)
6.3.3 North America Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
6.4 North America Premature Ejaculation Treatment Market Size by Country
6.4.1 North America Premature Ejaculation Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Premature Ejaculation Treatment Market Size by Country (2018-2023)
6.4.3 North America Premature Ejaculation Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Premature Ejaculation Treatment Market Size (2018-2029)
7.2 Europe Premature Ejaculation Treatment Market Size by Type
7.2.1 Europe Premature Ejaculation Treatment Market Size by Type (2018-2023)
7.2.2 Europe Premature Ejaculation Treatment Market Size by Type (2024-2029)
7.2.3 Europe Premature Ejaculation Treatment Market Share by Type (2018-2029)
7.3 Europe Premature Ejaculation Treatment Market Size by Distribution Channel
7.3.1 Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023)
7.3.2 Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029)
7.3.3 Europe Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
7.4 Europe Premature Ejaculation Treatment Market Size by Country
7.4.1 Europe Premature Ejaculation Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Premature Ejaculation Treatment Market Size by Country (2018-2023)
7.4.3 Europe Premature Ejaculation Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Premature Ejaculation Treatment Market Size (2018-2029)
8.2 China Premature Ejaculation Treatment Market Size by Type
8.2.1 China Premature Ejaculation Treatment Market Size by Type (2018-2023)
8.2.2 China Premature Ejaculation Treatment Market Size by Type (2024-2029)
8.2.3 China Premature Ejaculation Treatment Market Share by Type (2018-2029)
8.3 China Premature Ejaculation Treatment Market Size by Distribution Channel
8.3.1 China Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023)
8.3.2 China Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029)
8.3.3 China Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
9 Asia (excluding China)
9.1 Asia Premature Ejaculation Treatment Market Size (2018-2029)
9.2 Asia Premature Ejaculation Treatment Market Size by Type
9.2.1 Asia Premature Ejaculation Treatment Market Size by Type (2018-2023)
9.2.2 Asia Premature Ejaculation Treatment Market Size by Type (2024-2029)
9.2.3 Asia Premature Ejaculation Treatment Market Share by Type (2018-2029)
9.3 Asia Premature Ejaculation Treatment Market Size by Distribution Channel
9.3.1 Asia Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023)
9.3.2 Asia Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029)
9.3.3 Asia Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
9.4 Asia Premature Ejaculation Treatment Market Size by Region
9.4.1 Asia Premature Ejaculation Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Premature Ejaculation Treatment Market Size by Region (2018-2023)
9.4.3 Asia Premature Ejaculation Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Distribution Channel
10.3.1 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023)
10.3.2 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029)
10.3.3 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
10.4 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Premature Ejaculation Treatment Introduction
11.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Premature Ejaculation Treatment Introduction
11.2.4 Novartis Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction
11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.3.5 Eli Lilly Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Premature Ejaculation Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.4.5 Johnson & Johnson Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Premature Ejaculation Treatment Introduction
11.6.4 Bayer Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.6.5 Bayer Recent Developments
11.7 Menarini
11.7.1 Menarini Company Details
11.7.2 Menarini Business Overview
11.7.3 Menarini Premature Ejaculation Treatment Introduction
11.7.4 Menarini Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.7.5 Menarini Recent Developments
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Teva Business Overview
11.8.3 Teva Premature Ejaculation Treatment Introduction
11.8.4 Teva Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.8.5 Teva Recent Developments
11.9 Sunrise Pharma
11.9.1 Sunrise Pharma Company Details
11.9.2 Sunrise Pharma Business Overview
11.9.3 Sunrise Pharma Premature Ejaculation Treatment Introduction
11.9.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.9.5 Sunrise Pharma Recent Developments
11.10 Regent Pacific
11.10.1 Regent Pacific Company Details
11.10.2 Regent Pacific Business Overview
11.10.3 Regent Pacific Premature Ejaculation Treatment Introduction
11.10.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.10.5 Regent Pacific Recent Developments
11.11 Torrent Pharma
11.11.1 Torrent Pharma Company Details
11.11.2 Torrent Pharma Business Overview
11.11.3 Torrent Pharma Premature Ejaculation Treatment Introduction
11.11.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.11.5 Torrent Pharma Recent Developments
11.12 Vivus
11.12.1 Vivus Company Details
11.12.2 Vivus Business Overview
11.12.3 Vivus Premature Ejaculation Treatment Introduction
11.12.4 Vivus Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.12.5 Vivus Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Premature Ejaculation Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Antidepressants(SSRIs)
    Table 3. Key Players of Phosphodiesterase-5 Inhibitors
    Table 4. Key Players of Topical Anesthetics
    Table 5. Key Players of Analgesics
    Table 6. Key Players of Other Treatment
    Table 7. Global Premature Ejaculation Treatment Market Size Growth Rate by Distribution Channel (US$ Million), 2018 VS 2022 VS 2029
    Table 8. Global Premature Ejaculation Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Premature Ejaculation Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Premature Ejaculation Treatment Market Share by Region (2018-2023)
    Table 11. Global Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Premature Ejaculation Treatment Market Share by Region (2024-2029)
    Table 13. Premature Ejaculation Treatment Market Trends
    Table 14. Premature Ejaculation Treatment Market Drivers
    Table 15. Premature Ejaculation Treatment Market Challenges
    Table 16. Premature Ejaculation Treatment Market Restraints
    Table 17. Global Premature Ejaculation Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Premature Ejaculation Treatment Revenue Share by Players (2018-2023)
    Table 19. Global Top Premature Ejaculation Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2022)
    Table 20. Global Premature Ejaculation Treatment Industry Ranking 2021 VS 2022 VS 2023
    Table 21. Global 5 Largest Players Market Share by Premature Ejaculation Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Global Key Players of Premature Ejaculation Treatment, Headquarters and Area Served
    Table 23. Global Key Players of Premature Ejaculation Treatment, Product and Application
    Table 24. Global Key Players of Premature Ejaculation Treatment, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Premature Ejaculation Treatment Revenue Market Share by Type (2018-2023)
    Table 28. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Premature Ejaculation Treatment Revenue Market Share by Type (2024-2029)
    Table 30. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
    Table 31. Global Premature Ejaculation Treatment Revenue Share by Distribution Channel (2018-2023)
    Table 32. Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
    Table 33. Global Premature Ejaculation Treatment Revenue Share by Distribution Channel (2024-2029)
    Table 34. North America Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 35. North America Premature Ejaculation Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 36. North America Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
    Table 37. North America Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029) & (US$ Million)
    Table 38. North America Premature Ejaculation Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. North America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 40. North America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Europe Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 42. Europe Premature Ejaculation Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 43. Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
    Table 44. Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029) & (US$ Million)
    Table 45. Europe Premature Ejaculation Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Europe Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Europe Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 48. China Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 49. China Premature Ejaculation Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 50. China Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
    Table 51. China Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029) & (US$ Million)
    Table 52. Asia Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 53. Asia Premature Ejaculation Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 54. Asia Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
    Table 55. Asia Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029) & (US$ Million)
    Table 56. Asia Premature Ejaculation Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 57. Asia Premature Ejaculation Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 58. Asia Premature Ejaculation Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2024-2029) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Premature Ejaculation Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 64. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Premature Ejaculation Treatment Product
    Table 69. Pfizer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 70. Pfizer Recent Developments
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Premature Ejaculation Treatment Product
    Table 74. Novartis Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 75. Novartis Recent Developments
    Table 76. Eli Lilly Company Details
    Table 77. Eli Lilly Business Overview
    Table 78. Eli Lilly Premature Ejaculation Treatment Product
    Table 79. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 80. Eli Lilly Recent Developments
    Table 81. Johnson & Johnson Company Details
    Table 82. Johnson & Johnson Business Overview
    Table 83. Johnson & Johnson Premature Ejaculation Treatment Product
    Table 84. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 85. Johnson & Johnson Recent Developments
    Table 86. GlaxoSmithKline Company Details
    Table 87. GlaxoSmithKline Business Overview
    Table 88. GlaxoSmithKline Premature Ejaculation Treatment Product
    Table 89. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 90. GlaxoSmithKline Recent Developments
    Table 91. Bayer Company Details
    Table 92. Bayer Business Overview
    Table 93. Bayer Premature Ejaculation Treatment Product
    Table 94. Bayer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 95. Bayer Recent Developments
    Table 96. Menarini Company Details
    Table 97. Menarini Business Overview
    Table 98. Menarini Premature Ejaculation Treatment Product
    Table 99. Menarini Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 100. Menarini Recent Developments
    Table 101. Teva Company Details
    Table 102. Teva Business Overview
    Table 103. Teva Premature Ejaculation Treatment Product
    Table 104. Teva Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 105. Teva Recent Developments
    Table 106. Sunrise Pharma Company Details
    Table 107. Sunrise Pharma Business Overview
    Table 108. Sunrise Pharma Premature Ejaculation Treatment Product
    Table 109. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 110. Sunrise Pharma Recent Developments
    Table 111. Regent Pacific Company Details
    Table 112. Regent Pacific Business Overview
    Table 113. Regent Pacific Premature Ejaculation Treatment Product
    Table 114. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 115. Regent Pacific Recent Developments
    Table 116. Torrent Pharma Company Details
    Table 117. Torrent Pharma Business Overview
    Table 118. Torrent Pharma Premature Ejaculation Treatment Product
    Table 119. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 120. Torrent Pharma Recent Developments
    Table 121. Vivus Company Details
    Table 122. Vivus Business Overview
    Table 123. Vivus Premature Ejaculation Treatment Product
    Table 124. Vivus Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
    Table 125. Vivus Recent Developments
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Premature Ejaculation Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Premature Ejaculation Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Antidepressants(SSRIs) Features
    Figure 4. Phosphodiesterase-5 Inhibitors Features
    Figure 5. Topical Anesthetics Features
    Figure 6. Analgesics Features
    Figure 7. Other Treatment Features
    Figure 8. Global Premature Ejaculation Treatment Market Size Growth Rate by Distribution Channel, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 9. Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2022 VS 2029
    Figure 10. Hospital Case Studies
    Figure 11. Retail Pharmacy Case Studies
    Figure 12. Online Pharmacy Case Studies
    Figure 13. Other Case Studies
    Figure 14. Premature Ejaculation Treatment Report Years Considered
    Figure 15. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Premature Ejaculation Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Premature Ejaculation Treatment Market Share by Region: 2022 VS 2029
    Figure 18. Global Premature Ejaculation Treatment Market Share by Players in 2022
    Figure 19. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Premature Ejaculation Treatment Revenue in 2022
    Figure 21. North America Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Premature Ejaculation Treatment Market Share by Type (2018-2029)
    Figure 23. North America Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
    Figure 24. North America Premature Ejaculation Treatment Market Share by Country (2018-2029)
    Figure 25. United States Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Canada Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Europe Premature Ejaculation Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 28. Europe Premature Ejaculation Treatment Market Share by Type (2018-2029)
    Figure 29. Europe Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
    Figure 30. Europe Premature Ejaculation Treatment Market Share by Country (2018-2029)
    Figure 31. Germany Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. France Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Italy Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Russia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Nordic Countries Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. China Premature Ejaculation Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 38. China Premature Ejaculation Treatment Market Share by Type (2018-2029)
    Figure 39. China Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
    Figure 40. Asia Premature Ejaculation Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 41. Asia Premature Ejaculation Treatment Market Share by Type (2018-2029)
    Figure 42. Asia Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
    Figure 43. Asia Premature Ejaculation Treatment Market Share by Region (2018-2029)
    Figure 44. Japan Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. China Taiwan Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. India Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Australia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Share by Type (2018-2029)
    Figure 52. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Share by Distribution Channel (2018-2029)
    Figure 53. Middle East, Africa, and Latin America Premature Ejaculation Treatment Market Share by Country (2018-2029)
    Figure 54. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Turkey Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Saudi Arabia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. Israel Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 59. GCC Countries Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 60. Pfizer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 61. Novartis Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 62. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 64. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 65. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 66. Menarini Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 67. Teva Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 68. Sunrise Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 69. Regent Pacific Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 70. Torrent Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 71. Vivus Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS